Genotech (XKRX:066830) EV-to-EBIT : -11.95 (As of May. 27, 2024)

Genotech EV-to-EBIT Chart

Genotech Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial				47.39	5.08	5.55	5.69	-19.78

Genotech Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT	Get a 7-Day Free Trial				47.39	5.08	5.55	5.69	-19.78

Competitive Comparison of Genotech's EV-to-EBIT

For the Biotechnology subindustry, Genotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genotech's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Genotech's EV-to-EBIT falls into.

Genotech EV-to-EBIT Calculation

Genotech's EV-to-EBIT for today is calculated as:

Genotech's current Enterprise Value is ₩2,875 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-241 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genotech  (XKRX:066830) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Genotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Genotech's Enterprise Value for the quarter that ended in Dec. 2023 was ₩4,757 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-241 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Genotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Genotech (XKRX:066830) Business Description